Novus Acquisition & Development Corp (NDEV) Fair Value & Analysis
Financial Services · US · Market cap $1.8M
Novus Acquisition & Development Corp
NDEV · US
Strengths
Risks
Fair value as of: Aug 25, 2026
From 4 valuation models · updated today
A solid business, currently priced close to our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- The models converge in a tight band ($0.0141 to $0.0154), unusually little disagreement for a valuation.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 25, 2026.
How to read this chart
60‑month range $0.0105 – $0.1540 · fair‑value band $0.0141 – $0.0154 · the $0.0139 price screens below the $0.0147 fair value. Dashed = 300-day average. As of Aug 25, 2026.
Analysis
Novus Acquisition & Development Corp (NDEV) currently trades at $0.0139, while our model-based Fair Value estimate is $0.0147, implying the stock looks roughly 5.8% fairly valued today. The Quality Score stands at 67/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Novus Acquisition & Development Corp generated revenue of $266K at a net margin of 35.9%. Revenue grew 50.8% year over year. It earns a return on equity of 6.4%. The stock trades on a trailing P/E of 13.9. Fundamentals as of Aug 25, 2026
Our scenario range runs from $0.0141 (bear case) to $0.0154 (bull case); at $0.0139, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 65% below its 52-week high and 54% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -22% fair-value upside, at 6%, NDEV screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 4 models by family
Widest divergence: Multiples ($0.0200) versus Asset-Based ($0.0100). Highest evidence: Residual Income (76).
Notify me when NDEV reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 25, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 67 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Novus Acquisition & Development Corp., through its subsidiary, WCIG Insurance Service, Inc., operates as an insurance company in California. It offers health policies in CBD concentrate cannabis space; benefit plans, such as dental, vision, hearing, and telemedicine; and THC health plans. The company was formerly known as BrandQuest Development Group, Inc.
Full company description
Novus Acquisition & Development Corp., through its subsidiary, WCIG Insurance Service, Inc., operates as an insurance company in California. It offers health policies in CBD concentrate cannabis space; benefit plans, such as dental, vision, hearing, and telemedicine; and THC health plans. The company was formerly known as BrandQuest Development Group, Inc. and changed its name to Novus Acquisition & Development Corp. in April 2009. Novus Acquisition & Development Corp. was incorporated in 1996 and is based in Miami, Florida.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Novus Acquisition & Development Corp reported revenue of $405K in FY2025 versus $266K in FY2021, a compound +11.0%/yr. Reported net income was $195K in FY2025, compounding +19.6%/yr from FY2021.
Watch NDEV: get an alert when its fair value changes →
Peer Group
Insurance - Diversified · 84 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Insurance - Diversified median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate (as of Aug 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Berkshire Hathaway Inc BRKB | $510.00 | $396.30 | -22% |
| Allianz SE ALV | €437.80 | €266.04 | -39% |
| Zurich Insurance Group ZURN | CHF 586.80 | CHF 330.51 | -44% |
| AXA SA CS | €43.72 | €39.90 | -9% |
| Assicurazioni Generali S.p.A G | €43.88 | €13.91 | -68% |
| Sun Life Financial Inc SLF | C$108.80 | C$57.05 | -48% |
| American International Group AIG | $76.14 | $80.91 | +6% |
| The Hartford Insurance Group HIG | $137.12 | $133.10 | -3% |
| Arch Capital Group ACGL | $97.29 | $124.45 | +28% |
| Swiss Life Holding SLHN | CHF 932.80 | CHF 425.23 | -54% |
Compare Novus Acquisition & Development Corp with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Novus Acquisition & Development Corp (NDEV) overvalued or undervalued?
What is the fair value of NDEV?
What is the quality score of NDEV?
What is the revenue of Novus Acquisition & Development Corp (NDEV)?
What is the net profit margin of NDEV?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Novus Acquisition & Development Corp and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.